Developing innovative pharmaceutical drugs and technologies is a complicated process. A robust chemistry, manufacturing, and controls (CMC) strategy is critical to determining a new drug’s success or ...
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the appointment of Charles Winter as Senior Vice President ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback